Home > Research home > News

Research news

Select Category
Thursday 24th January 2013

South Americans want policy makers to put ethics above price

South Americans want policy makers to put ethics above price
Description
Researchers at Royal Holloway have found that Brazilians and Chileans want the state to buy on social and environmental criteria, not just on price.
Date:
24/01/2013
Thursday 17th January 2013

Government funding for 'super-material'

Government funding for 'super-material'
Description
Royal Holloway is among a select group of universities to receive £21.5 million in government funding to explore commercial uses for graphene.
Date:
17/01/2013
Saturday 5th January 2013

City-living helped us evolve immunity to disease

City-living helped us evolve immunity to disease
Description
A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.
Date:
05/01/2013
Tuesday 4th December 2012

Scientists discover tobacco tree that could be used as biofuel

Description
Researchers at Royal Holloway have been awarded a grant from the European Union, after identifying a tobacco tree that could produce biofuels
Date:
04/12/2012
Wednesday 28th November 2012

Research shows lemmings were wiped out by Ice Age's climate change

Description
Small mammal populations across Europe were wiped out multiple times during the last Ice Age, due to an inability to deal with rapid climate change, according the research published in the journal Proceedings of the Natural Academy of Sciences.
Date:
28/11/2012

Global scientific collaboration wins EU grant award to perform clinical trials in Duchenne Muscular Dystrophy

Description
A team of scientists from several European countries and the USA, led by UCL scientist Prof Francesco Muntoni, Dubowitz Neuromuscular Centre, Institute of Child Health and including Professor George Dickson from Royal Holloway's School of Biological Sciences, have won an EU Health Innovation-1 2012 Collaborative research grant of €5.5 million to perform a clinical trial to test a novel drug treatment in Duchenne muscular dystrophy (DMD) boys.
Date:
28/11/2012
Monday 26th November 2012

Discovery offers new treatment for epilepsy

Description
New drugs derived from components of a specific diet used by children with severe, drug-resistant epilepsy could offer a new treatment, according to research published today in the journal Neuropharmacology.
Date:
26/11/2012
Monday 5th November 2012

Government's £39 million grant to include vaccine research at Royal Holloway

Description
It has been announced that Royal Holloway will be among a select group of small and medium-sized businesses (SMEs) and other universities to receive the first substantial awards from the £180 million Biomedical Catalyst. Grants totaling £39 million have been awarded to accelerate the development of innovative solutions to healthcare challenges.
Date:
05/11/2012
Tuesday 30th October 2012

Next Generation Vaccines – eliminating the use of needles

Description
Scientists at Royal Holloway, University of London have developed a pioneering new method of oral vaccination which could help boost immunity to TB and influenza, as well as prevent C. difficile for which there is currently no vaccine.
Date:
30/10/2012
Friday 26th October 2012

Research suggests exposure to multiple pesticides increases risks for bumblebees

Description
The behaviour of bees and the success of their colonies are significantly affected when exposed to a combination of pesticides, according to new research from the School of Biological Sciences at Royal Holloway, University of London published today in Nature.
Date:
26/10/2012
Displaying 11 to 20 of 103
Previous 1 2 3 4 5 Next

 
 
 

Comment on this page

Did you find the information you were looking for? Is there a broken link or content that needs updating? Let us know so we can improve the page.

Note: If you need further information or have a question that cannot be satisfied by this page, please call our switchboard on +44 (0)1784 434455.

This window will close when you submit your comment.

Add Your Feedback
Close|